ALK is driving neuroblastoma (NB) and RET has been shown to be a downstream target of ALK signaling in NB. To get a bett...
ALK is a tyrosine kinase receptor and oncogene in neuroblastoma (NB). The receptor is activated by the ALKAL2 ligand, bu...
ALK is a tyrosine kinase receptor and oncogene in neuroblastoma (NB). The receptor is activated by the ALKAL2 ligand, bu...
...ALK inhibitors occurs. Exploring these mechanisms of resistance, we found that EML4-ALK cells resistant to ALK inhibitor...
...ALK inhibitors occurs. Exploring these mechanisms of resistance, we found that EML4-ALK cells resistant to ALK inhibitor...
Despite the successful use of drugs targeting the MAPK signaling pathway and immunotherapy in melanoma, the majority of ...
Anaplastic Lymphoma Kinase (ALK) is a tyrosine kinase receptor which is a clinical target of major interest in cancer, i...
...ALK) and multitarget TKIs in terms of cancer cell growth, signaling cascades inhibition, and changes in gene expression ...
...ALK are driver oncogenes both of which are specifically expressed during early neurogenesis. This is in line with the as...
...ALK transgenic mice following Notch1 expression. In support, we show that T cell receptor (TCR) rearrangements are aberr...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269